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AP-3 regulates PAR1 ubiquitin-independent MVB/
lysosomal sorting via an ALIX-mediated pathway
Michael R. Doresa, May M. Paingb, Huilan Lina, William A. Montagnea, Adriano Marchesec,
and JoAnn Trejoa
a

Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093;
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, 63110;
c
Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago Stritch School of Medicine,
Maywood, IL 60153
b

ABSTRACT The sorting of signaling receptors within the endocytic system is important for
appropriate cellular responses. After activation, receptors are trafﬁcked to early endosomes
and either recycled or sorted to lysosomes and degraded. Most receptors trafﬁcked to lysosomes are modiﬁed with ubiquitin and recruited into an endosomal subdomain enriched in
hepatocyte growth factor–regulated tyrosine kinase substrate (HRS), a ubiquitin-binding
component of the endosomal-sorting complex required for transport (ESCRT) machinery, and
then sorted into intraluminal vesicles (ILVs) of multivesicular bodies (MVBs)/lysosomes. However, not all receptors use ubiquitin or the canonical ESCRT machinery to sort to MVBs/lysosomes. This is exempliﬁed by protease-activated receptor-1 (PAR1), a G protein–coupled receptor for thrombin, which sorts to lysosomes independent of ubiquitination and HRS. We
recently showed that the adaptor protein ALIX binds to PAR1, recruits ESCRT-III, and mediates receptor sorting to ILVs of MVBs. However, the mechanism that initiates PAR1 sorting at
the early endosome is not known. We now report that the adaptor protein complex-3 (AP-3)
regulates PAR1 ubiquitin-independent sorting to MVBs through an ALIX-dependent pathway.
AP-3 binds to a PAR1 cytoplasmic tail–localized tyrosine-based motif and mediates PAR1
lysosomal degradation independent of ubiquitination. Moreover, AP-3 facilitates PAR1 interaction with ALIX, suggesting that AP-3 functions before PAR1 engagement of ALIX and MVB/
lysosomal sorting.
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INTRODUCTION
The most abundant class of signaling receptors expressed in the
mammalian genome is that of G protein–coupled receptors (GPCRs), which mediate cellular responses to numerous physiological
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ESCRT, endosomal-sorting complex required for transport; GFP, green ﬂuorescent protein; GPCR, G protein–coupled receptor; HRS, hepatocyte growth factor–
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stimuli. GPCRs signal predominantly to heterotrimeric G proteins at
the plasma membrane and can also signal from subcellular compartments. Once activated, GPCRs are rapidly desensitized, internalized, and then sorted within the endocytic system and recycled or
degraded in lysosomes. The trafﬁcking of GPCRs through the endocytic pathway is critical for controlling the temporal and spatial ﬁdelity of signaling responses. GPCR trafﬁcking facilitates receptor resensitization, signaling through scaffolds on endosomes and signal
termination via degradation in lysosomes (Marchese et al., 2008).
Moreover, dysregulated GPCR trafﬁcking results in aberrant signaling that contributes to various pathological conditions, including
cancer progression (Booden et al., 2004; Li et al., 2004). The precise
mechanisms that control trafﬁcking of GPCRs within the endocytic
system have not been clearly deﬁned.
After internalization, vesicles containing GPCRs fuse with early
endosomes, an endocytic compartment that functions mainly to sort
cargo. Internalized GPCRs are then either sorted to tubular sorting
endosomes and recycled or sequestered in early endosomes and
Molecular Biology of the Cell

sorted to lysosomes for degradation. The sorting of most receptors
from endosomes to lysosomes occurs via interaction with endosomalsorting complex required for transport (ESCRT) proteins. The ESCRT
machinery comprises four distinct ESCRT complexes that function
sequentially to coordinate the sorting of ubiquitinated receptors into
intraluminal vesicles (ILVs) of multivesicular bodies (MVBs; Hurley and
Hanson, 2010). ESCRT-dependent sorting of ubiquitinated receptors
is initiated at an early endosomal subdomain enriched in hepatocyte
growth factor–regulated tyrosine kinase substrate (HRS) protein, an
ESCRT-0 component, and clathrin (Raiborg et al., 2002). HRS interacts directly with ubiquitinated cargo and ESCRT-I, which also binds
to ubiquitin and ESCRT-II. The ESCRT-III complex is then recruited,
assembles on endosomal membranes, and facilitates ILV scission.
Vps4, an AAA-ATPase, disassembles and recycles ESCRT-III at the
MVB and is a process essential for ESCRT function.
Many mammalian GPCRs are modiﬁed with ubiquitin and sorted
to lysosomes for degradation through the ESCRT pathway. This is
best characterized for the G protein–coupled chemokine CXCR4
receptor and protease-activated receptor-2 (PAR2; Marchese et al.,
2003; Hasdemir et al., 2007; Malerod et al., 2007; Dores et al.,
2012). However, not all GPCRs require direct ubiquitination or all
ubiquitin-binding components of the ESCRT machinery for lysosomal sorting. A ubiquitination-deﬁcient mutant of the delta-opioid
receptor (DOR) and the calcitonin-like (CL) receptor—a GPCR that is
not ubiquitinated—trafﬁc to MVBs/lysosomes like wild-type receptor (Hislop et al., 2004; Cottrell et al., 2007; Henry et al., 2011). Despite not being directly ubiquitinated, DOR and CL receptors sort to
lysosomes through an HRS-dependent pathway, suggesting that
sorting of receptors is initiated at the HRS-enriched subdomain of
the early endosome and mediated by the canonical ESCRT machinery. In contrast to DOR and CL receptor, we previously showed that
PAR1, a GPCR for thrombin, sorts to ILVs of MVBs independent of
ubiquitin and ubiquitin-binding ESCRT components HRS and
Tsg101 (Gullapalli et al., 2006; Wolfe et al., 2007; Dores et al., 2012).
We also discovered that the adaptor protein ALIX binds directly to
PAR1 via an YPX3L motif, recruits ESCRT-III, and mediates receptor
sorting to ILVs of MVBs independent of ubiquitination (Dores et al.,
2012). Thus PAR1 bypasses the requirement for ubiquitin and ubiquitin-binding ESCRT components for sorting from endosomes to
MVBs/lysosomes. However, the mechanism by which sorting of
PAR1 is initiated at the early endosome remains unclear.
The adaptor protein complex-3 (AP-3) is enriched at the early
sorting endosome and localizes to tubulovesicular budding proﬁles
(Dell’Angelica et al., 1998; Peden et al., 2004; Theos et al., 2005). In
contrast, HRS localizes to a distinct bilayered subdomain of early
endosomes that is devoid of AP-3 (Sachse et al., 2002). AP-3 is a
heterotetrameric complex comprising B3, D, μ3, and S3 adaptin subunits and functions in sorting of lysosomal-associated membrane
proteins (LAMPs) from endosomes to lysosomes that accumulate at
the limiting membrane of MVBs/lysosomes, as well as CD63, a protein that localizes to ILVs of MVBs (Dell’Angelica et al., 1999; Rous
et al., 2002). The B3 adaptin subunit of AP-3 contains a consensus
clathrin-binding site, directly interacts with clathrin, and colocalizes
with clathrin on endosomal membranes (Dell’Angelica et al., 1998;
Peden et al., 2004), whereas the μ3 subunit of AP-3 interacts with
tyrosine-based YXXØ motifs, where Y is the critical tyrosine, X is any
amino acid, and Ø is a bulky hydrophobic residue, present in the
cytoplasmic regions of cargo proteins and mediates lysosomal sorting (Dell’Angelica et al., 1999; Rous et al., 2002). Thus AP-3 regulates sorting of proteins to ILVs of MVBs and lysosomes, but whether
the AP-3–enriched subdomain of early endosomes is used by signaling receptors to access ILVs of MVBs is not known.
Volume 23 September 15, 2012

The adaptor protein ALIX binds to PAR1 and ESCRT-III to facilitate receptor sorting to ILVs of MVBs independent of ubiquitination
(Dores et al., 2012). However, the mechanism responsible for initiating ubiquitin-independent MVB/lysosomal sorting of PAR1 at the
early endosome remains unknown, since HRS is not essential for
PAR1 lysosomal sorting (Gullapalli et al., 2006). Given these observations and the presence of tyrosine sorting motifs in the cytoplasmic tail (C-tail) of PAR1, we examined the function of AP-3. In the
present study, we demonstrate that AP-3 binds to a PAR1 C-tail–localized, tyrosine-based motif and regulates lysosomal degradation
of the receptor independent of ubiquitination. We further show that
AP-3 is required for PAR1 association with ALIX and that a mutant
PAR1 defective in AP-3 binding fails to sort to intraluminal membranes—compartments protected from proteinase K. Thus AP-3
regulates PAR1 endosomal sorting before interaction with ALIX and
ILV sorting at the MVB.

RESULTS
AP-3 association with activated PAR1
To assess the role of AP-3 in intracellular trafﬁcking of PAR1, we ﬁrst
examined whether the receptor colocalized with endogenous AP-3.
HeLa cells stably expressing an N-terminal FLAG-tagged PAR1 were
incubated with anti-FLAG antibody at 4°C. Under these conditions
only cell surface receptors are labeled with antibody. Cells were then
left untreated (0 min) or treated with the agonist peptide SFLLRN for
10 min at 37°C, processed, and immunostained using the SA4 anti–
D-adaptin antibody as described (Berger et al., 2007) and imaged by
confocal microscopy. In untreated control cells, PAR1 localized mainly
to the cell surface (Figure 1A), whereas endogenous AP-3 appeared
as punctae distributed throughout the cytoplasm, consistent with
previously reported studies (Peden et al., 2004; Berger et al., 2007).
After activation, PAR1 internalized to endocytic vesicles that colocalized with endogenous AP-3 (Figure 1A). The colocalization of PAR1
and AP-3 was veriﬁed by determining Pearson’s r (Figure 1A). To further conﬁrm the presence of PAR1 and AP-3 on endosomes, we examined colocalization in cells expressing a constitutively active Rab5
Q79L mutant, which perturbs proper transport and fusion of endocytic vesicles, resulting in enlarged endosomes (Stenmark et al.,
1994). In unstimulated cells, PAR1 was present mainly on the plasma
membrane, whereas endogenous AP-3 localized to the limiting
membrane of enlarged endosomes induced by coexpression of the
Rab5 Q79L mutant (Figure 1B). After agonist stimulation for 10 min,
PAR1 redistributed to enlarged endosomes and exhibited considerable colocalization with AP-3 (Figure 1B). These ﬁndings suggest that
activated PAR1 sorts to an AP-3–positive endosomal compartment.
We next determined whether activated PAR1 associated with
AP-3 in HeLa cells by coimmunoprecipitation. Cells expressing PAR1
were incubated with agonist for various times at 37°C, lysates were
immunoprecipitated, and the amount of endogenous AP-3 associated with the receptor was determined by immunoblotting for the
D-adaptin subunit and quantitated. In contrast to untreated control
cells, a marked, approximately threefold increase in endogenous
AP-3 associated with PAR1 was observed after 10 min of agonist
stimulation, and the association appeared to diminish at 20 min
(Figure 1C, lanes 3–5). After 40 min of agonist exposure PAR1 coimmunoprecipitation with endogenous AP-3 was considerably reduced, consistent with substantial degradation of activated PAR1
observed at this time (Figure 1C, lane 6). However, neither PAR1 nor
AP-3 was detected in immunoprecipitates from immunoglobulin G
(IgG) control (Figure 1C, lanes 1 and 2). These results indicate that
activated and internalized PAR1 associates with AP-3 and transits
through an AP-3–positive endosomal compartment.
AP-3–dependent GPCR lysosomal sorting
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FIGURE 1: PAR1 colocalization and coassociation with AP-3. (A) HeLa cells expressing
N-terminal FLAG-tagged PAR1 were incubated with anti-FLAG antibody for 1 h at 4°C to label
cell surface receptors and then stimulated for 10 min with 100 μM SFLLRN at 37°C. Cells were
ﬁxed, permeabilized, and immunostained for PAR1 (red) and endogenous D-adaptin (green)
using mouse SA4 anti–D-adaptin antibody and imaged by confocal microscopy. Scale bar, 10 μm.
Inset, magniﬁcation of the boxed area. The colocalization of PAR1 with AP-3 appears as the
yellow color in the merged image and was quantitated by determining Pearson’s r from six
different cells. The difference in colocalization between untreated and agonist-stimulated PAR1
colocalization with AP-3 was signiﬁcant (***p < 0.001; n  6) as determined by Student’s t test.
(B) HeLa cells expressing FLAG-PAR1 were transiently transfected with Rab5 Q79L mutant
tagged with GFP. After transfection, cells were treated and processed as described to detect
PAR1 and endogenous AP-3 expression. Arrowheads indicate enlarged Rab5 Q79L–positive
endosomes. (C) HeLa cells expressing FLAG-tagged PAR1 were left untreated (0 min) or treated
with 100 μM SFLLRN for 10, 20, or 40 min at 37°C. Cells were lysed, and equivalent amounts of
cell lysates were used for immunoprecipitation with M2 anti-FLAG antibody or IgG.
Immunoprecipitates were resolved by SDS–PAGE and immunoblotted with anti–D-adaptin
antibody to detect endogenous AP-3. Membranes were stripped and reprobed with anti-PAR1
antibody. The asterisk indicates a nonspeciﬁc band. Endogenous D-adaptin expression in total
cell lysates was examined as a control. The data (mean o SD) represent the amount of
coprecipitated D-adaptin normalized to the amount of immunoprecipitated PAR1 at various
times of agonist stimulation and was signiﬁcant, as determined by Student’s t test (**p < 0.01;
n  3). These data are representative of at least three independent experiments.

PAR1 lysosomal degradation is regulated by AP-3
To assess AP-3 function in PAR1 lysosomal degradation, we used
small interfering RNAs (siRNAs) that target the D-adaptin subunit of
AP-3 to deplete HeLa cells of the endogenous AP-3 complex. The
loss of D-adaptin subunit expression results in degradation of other
adaptin subunits and disruption of AP-3 function (Peden et al.,
2002). The expression of D-adaptin was virtually abolished in
3614 | M. R. Dores et al.

D-adaptin siRNA–transfected cells compared
to nonspeciﬁc siRNA–transfected control
cells (Figure 2A). In control siRNA–transfected cells, exposure to agonist for 60 min
caused an ^50% decrease in PAR1 protein,
and after 90 min an ^70% loss of receptor
protein was detected (Figure 2A, lanes 1–3).
These ﬁndings are consistent with the extent of agonist-induced PAR1 degradation
typically observed in HeLa cells (Dores et al.,
2012). In contrast, activated PAR1 degradation was markedly attenuated in cells lacking endogenous AP-3 (Figure 2A, lanes
4–6); only ^10–30% loss of receptor protein
was observed after incubation with agonist
for 60 or 90 min, respectively. These data
suggest that AP-3 regulates lysosomal degradation of PAR1.
We next examined whether impaired
PAR1 degradation observed in AP-3–depleted cells resulted from defects in receptor internalization. PAR1-expressing HeLa
cells were incubated in the absence or presence of agonist peptide and ﬁxed, and the
amount of receptor remaining on the cell
surface was quantitated by enzyme-linked
immunosorbent assay (ELISA). In the absence of agonist stimulation, HeLa cells
transiently transfected with D-adaptin–
speciﬁc siRNAs displayed a modest increase
in PAR1 cell surface expression compared
with nonspeciﬁc siRNA–transfected control
cells (Figure 2B). However, agonist induced
a substantial and comparable amount of
PAR1 internalization in nonspeciﬁc and Dadaptin siRNA–transfected cells (Figure 2B);
an ^40% loss of surface receptor was detected after 10 min of agonist incubation in
both conditions. Immunoﬂuorescence microscopy studies also revealed robust internalization of PAR1 after agonist stimulation
in control and D-adaptin–depleted cells
(Figure 2C). Taken together, these results indicate that internalization of activated PAR1
is independent of AP-3.

AP-3 regulates GPCR lysosomal
degradation independent of
ubiquitination

CXCR4 and PAR2 are GPCRs that are directly modiﬁed with ubiquitin and use the
canonical ESCRT machinery for lysosomal
sorting (Marchese et al., 2003; Hasdemir
et al., 2007; Malerod et al., 2007; Dores
et al., 2012). To examine whether the AP-3–
regulated lysosomal degradation pathway of PAR1 is distinct from
ubiquitin-dependent GPCR lysosomal sorting, we examined the
function of AP-3 in agonist-stimulated degradation of CXCR4 and
PAR2. HeLa cells transfected with nonspeciﬁc or D-adaptin–speciﬁc
siRNAs were incubated with stromal-derived factor-1A (SDF-1A)—
the cognate ligand for CXCR4—and the amount of endogenous
CXCR4 protein remaining was determined by immunoblotting.
Molecular Biology of the Cell

Incubation with SDF-1A for 180 min caused a signiﬁcant ^50% decrease in CXCR4 protein in control siRNA–transfected cells (Figure
3A). SDF-1A–promoted CXCR4 degradation observed in D-adaptin–
depleted cells was comparable (Figure 3A), indicating that agonistpromoted CXCR4 degradation occurs independent of AP-3. HeLa
cells stably expressing FLAG-PAR2 transfected with nonspeciﬁc and
D-adaptin–speciﬁc siRNAs were stimulated with agonist, and receptor degradation was assessed. Similar to CXCR4, the extent of agonist-promoted PAR2 degradation was comparable in control and Dadaptin–deﬁcient cells (Figure 3B), suggesting that AP-3 is not
required for ubiquitin-dependent GPCR lysosomal degradation.
To conﬁrm that AP-3 mediates activated PAR1 lysosomal degradation independent of ubiquitination, we examined the capacity of
AP-3 to regulate the degradation of a ubiquitination-deﬁcient PAR1
mutant. We previously showed that the PAR1 0K mutant, which contains lysine-to-arginine mutations within the cytoplasmic domains,
signals normally but is defective in ubiquitination (Wolfe et al., 2007;
Chen et al., 2011). In addition, agonist stimulation of PAR1 0K mutant results in lysosomal sorting and degradation similar to wild-type
receptor (Wolfe et al., 2007; Dores et al., 2012). In nonspeciﬁc
siRNA–transfected control cells, a signiﬁcant ^50% decrease in PAR1
0K mutant protein was observed after 60 and 90 min of agonist incubation (Figure 3C, lanes 1–3), consistent with ubiquitin-independent lysosomal sorting of PAR1 (Dores et al., 2012). However, agonist-promoted degradation of PAR1 0K mutant was substantially
reduced in cells lacking endogenous AP-3 (Figure 3C, lanes 4–6);
only ^25% loss of receptor protein was observed after prolonged
agonist stimulation. These data suggest that AP-3 regulates GPCR
lysosomal sorting independent of receptor ubiquitination.

A PAR1 C-tail, tyrosine-based motif mediates AP-3 binding
and lysosomal degradation

FIGURE 2: AP-3 regulates agonist-induced PAR1 degradation but not
receptor internalization. (A) HeLa cells expressing FLAG-tagged PAR1
were transiently transfected with 50 nM nonspeciﬁc (ns) or D-adaptin–
speciﬁc siRNAs. Cells were pretreated with 10 μM cycloheximide for
90 min to block de novo protein synthesis, left unstimulated (0 min) or
stimulated with 100 μM SFLLRN for 60 or 90 min at 37°C. Equivalent
amount of cell lysates were immunoprecipitated with M2 anti-FLAG
antibody and examined by immunoblotting with anti-PAR1 antibody.
Cell lysates were analyzed for endogenous D-adaptin and actin as
controls. PAR1 degradation was quantitated, and the data (mean o
SD) shown are expressed as the fraction of PAR1 remaining compared
with untreated control cells determined at various times from three
independent experiments. The differences in PAR1 remaining in
control cells vs. D-adaptin siRNA–treated cells were signiﬁcant
(**p < 0.01, n  3; and ***p < 0.001, n  3) as determined by two-way
ANOVA. (B) HeLa cells expressing FLAG-tagged PAR1 were
transfected with 50 nM ns or D-adaptin siRNAs. Cells were pretreated
with cycloheximide as described, stimulated with 100 μM SFLLRN for
10 min, and ﬁxed, and the amount of PAR1 remaining on the cell
surface was quantitated by ELISA. The data shown (mean o SD) are
representative of three separate experiments. In both ns and
D-adaptin siRNA–treated cells, agonist stimulated a signiﬁcant loss of
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The μ3 subunit of AP-3 binds directly to tyrosine-based motifs localized within the cytoplasmic domains of transmembrane proteins
to facilitate lysosomal sorting (Bonifacino and Traub, 2003). The
PAR1 C-tail domain contains two tyrosine-based sorting signals
that conform to the YXXØ motif and could potentially mediate
AP-3 interaction (Figure 4A). The interaction between μ3-adaptin
subunit with tyrosine-based sequences is dependent on the critical
tyrosine and a bulky hydrophobic residue at the Y+3 position
(Bonifacino and Traub, 2003). Thus we ﬁrst investigated whether
PAR1 tyrosine-based motifs function in receptor lysosomal sorting
by examining agonist-stimulated degradation of mutants in which
the tyrosine (Y) and hydrophobic leucine (L) residues were mutated
to alanines (A; Figure 4A). In HeLa cells stably expressing PAR1 wild
type, a 60-min incubation with agonist caused ^50% loss of receptor protein (Figure 4B, lanes 1 and 2). Agonist-stimulated degradation of the PAR1 AKKAA mutant, in which the critical residues of the
tyrosine-based motif Y420KKL423L424 were mutated to A420KKA423A424, was comparable to that for wild-type receptor (Figure
4B, lanes 5 and 6). In contrast, agonist-promoted degradation of

PAR1 from the cell surface (** p < 0.01; n  3) as determined by
Student’s t test. (C) HeLa cells expressing FLAG-tagged PAR1 were
transiently transfected with 50 nM ns or D-adaptin siRNAs. Cell
surface PAR1 was prelabeled with anti-PAR1 antibody for 1 h at 4°C,
washed, and either left untreated (0 min) or treated with 100 μM
SFLLRN for 10 min at 37°C. Cells were ﬁxed, permeabilized, and
immunostained for PAR1 or D-adaptin and imaged by confocal
microscopy. Scale bar, 10 μm. The cells shown are representative of
many cells examined in multiple independent experiments.

AP-3–dependent GPCR lysosomal sorting
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the PAR1 ASIA mutant, containing alanine substitutions at the critical tyrosine and leucine
residues, was signiﬁcantly impaired and displayed only a modest ^23% decrease in receptor protein compared with wild-type receptor
after 60 min of agonist stimulation (Figure 4B,
lanes 3 and 4). These results indicate that the
PAR1 C-tail–proximal tyrosine sorting signal,
but not the distal tyrosine-based motif, is important for agonist-stimulated receptor lysosomal
degradation.
We next determined whether PAR1 interacts
with AP-3 via its proximal tyrosine-based motif
by examining coassociation after agonist stimulation. HeLa cells expressing similar amounts of
PAR1 wild type or ASIA mutant were incubated
with agonist for 10 or 20 min, receptors were
coimmunoprecipitated, and the association of
endogenous AP-3 was assessed by immunoblotting. Activation of PAR1 wild type resulted in
an increase in coimmunoprecipitated AP-3 that
peaked at 10 min and appeared to diminish after 20 min (Figure 4C, lanes 1–3) compared with
untreated control cells. In contrast to wild-type
PAR1, AP-3 interaction with the PAR1 ASIA mutant was substantially reduced in both control
and agonist-stimulated conditions (Figure 4C,
lanes 4–6). In addition, neither PAR1 nor Dadaptin was present in control IgG immunoprecipitates (Figure 4C, lanes 7 and 8). Thus the
PAR1 C-tail–proximal, tyrosine-based motif
serves as an AP-3–binding site and mediates receptor lysosomal degradation.

PAR1 ASIA mutant defective in AP-3
binding fails to sort to MVBs/lysosomes

FIGURE 3: AP-3 regulates GPCR lysosomal degradation independent of ubiquitination.
(A) HeLa cells expressing endogenous CXCR4 were transiently transfected with 50 nM
nonspeciﬁc (ns) or D-adaptin siRNAs. Cells were then treated in the absence (–) or presence
(+) of 10 nM SDF-1A for 180 min at 37°C. Cell lysates were prepared, and the amount of
endogenous CXCR4 remaining was determined by immunoblot and quantitated. The data
(mean o SD) show the extent of CXCR4 degradation and are expressed as the fraction of
CXCR4 remaining compared with untreated control cells; they are representative of three
independent experiments. (B) HeLa cells expressing FLAG-PAR2 were transfected with 50 nM
ns or D-adaptin siRNAs. Cells were then left unstimulated (–) or stimulated (+) with 100 μM
SLIGKV for 120 min, and the amount of PAR2 remaining was determined by immunoblot and
quantiﬁed. The data (mean o SD) represent the fraction of PAR2 remaining compared with
untreated control cells from three independent experiments. (C) HeLa cells expressing
ubiquitination-deﬁcient FLAG-PAR1 0K mutant were transfected with 50 nM ns or D-adaptin
siRNAs. Cells were stimulated with 100 μM SFLLRN for the indicated times, and equivalent
amounts of lysates were immunoprecipitated with M2 anti-FLAG antibody. The amount of
PAR1 0K remaining was determined by immunoblot and quantiﬁed. The data (mean o SD)
represent the fraction of PAR1 0K mutant remaining compared with untreated control cells
and are signiﬁcant (**p < 0.01; n  3) as determined by two-way ANOVA. Cell lysates were
immunoblotted with tubulin, D-adaptin, or actin antibodies as controls.
3616 | M. R. Dores et al.

To further delineate the mechanism by which disruption of AP-3 binding to the PAR1 proximal
tyrosine motif affects intracellular trafﬁcking, we
examined PAR1 ASIA mutant sorting to early endosomes and lysosomes after agonist stimulation. Both PAR1 wild type and ASIA mutant localized to the cell surface in the absence of agonist
(Figure 5, A and B). After 10 min of agonist stimulation, PAR1 wild type and ASIA mutant redistributed to endocytic vesicles and displayed marked
colocalization with the early endosome antigen-1
(EEA1), a marker of early endosomes (Figure 5A).
PAR1 colocalization with EEA1 was further evaluated by determining Pearson’s r for PAR1 wild
type (r  0.4 o 0.1, n  6) and ASIA mutant (r 
0.43 o 0.05, n  6) after 10 min of agonist incubation. However, after 20 or 30 min of agonist stimulation, neither PAR1 wild type nor ASIA mutant
remained in an EEA1-positive compartment
(Figure 5A), indicating that the receptors trafﬁc
from the early endosomal compartment. Thus a
PAR1 mutant with impaired AP-3 binding displays normal trafﬁcking to early endosomes.
Next we examined PAR1 ASIA mutant trafﬁcking to lysosomes by examining its colocalization with the lysosomal associated membrane
Molecular Biology of the Cell

FIGURE 4: A PAR1 proximal tyrosine-based motif mediates AP-3 interaction. (A) A schematic
of the PAR1 C-tail domain illustrating the proximal YSIL and distal YKKLL tyrosine sorting
motifs shaded in gray. The critical residues are underlined. PAR1 tyrosine motif mutants ASIA
and AKKAA are shown above the native sequence. (B) HeLa cells expressing comparable
amounts of FLAG-tagged PAR1 wild type (WT) or ASIA or AKKAA mutants pretreated with
10 μM cycloheximide were either left unstimulated (–) or stimulated (+) with 100 μM SFLLRN
for 60 min at 37°C. Cells were lysed, and PAR1 was immunoprecipitated from equivalent
amounts of cell lysates using an M2 anti-FLAG antibody. The amount of PAR1 remaining was
examined by immunoblot using an anti-PAR1 antibody and quantitated. The data (mean o
SD) shown are expressed as the fraction of PAR1 remaining compared with untreated control
cells representative of three independent experiments. The difference in the amount of
PAR1 WT vs. ASIA mutant detected after agonist stimulation was signiﬁcantly different
(***p < 0.001; n  3) as determined by two-way ANOVA. (C) HeLa cells expressing FLAGtagged PAR1 WT or ASIA mutant were left unstimulated (0 min) or stimulated with
100 μM SFLLRN for 10 or 20 min at 37°C. Equivalent amounts of cell lysates were
immunoprecipitated with M2 anti-FLAG antibody or IgG. Immunoprecipitates were then
analyzed for the presence of D-adaptin subunit. Membranes were stripped and reprobed
with antibody to detect PAR1. The amount of endogenous D-adaptin in total cell lysates
was detected by immunoblotting as a control.
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protein-1 (LAMP-1), a protein that resides in
late endosomes/lysosomes. As expected,
30 min of incubation with agonist resulted
in substantial PAR1 wild-type colocalization
with LAMP-1 (Figure 5B). This is consistent
with rapid PAR1 transport to lysosomes and
degradation (Dores et al., 2012). In contrast,
however, activation of the PAR1 ASIA mutant with agonist for 30 min failed to promote substantial colocalization with LAMP-1
(Figure 5B), suggesting that PAR1 ASIA
mutant is defective in lysosomal sorting. The
difference in receptor colocalization with
LAMP-1 was veriﬁed by determining Pearson’s r for PAR1 wild type (r  0.23 o 0.02, n 
6) and ASIA mutant (r  0.13 o 0.02, n  6).
At face value, these data suggest that disruption of the PAR1 proximal tyrosine-based
motif, an important AP-3–binding site, results in impaired sorting to lysosomes.
To further assess PAR1 ASIA mutant
MVB/lysosomal sorting, we examined the
capacity of the mutant receptor to remain at
the limiting membrane of endosomes or to
sort to an internal compartment by evaluating its sensitivity to proteinase K digestion
after activation and internalization. Proteinase K protection assays have been used to
examine sorting of the epidermal growth
factor receptor and PAR1 to ILVs of MVBs
(Sabatini and Blobel, 1970; Malerod et al.,
2007; Dores et al., 2012). HeLa cells expressing PAR1 wild type or ASIA mutant were
incubated in the absence or presence of
agonist for 15 min, gently washed, and permeabilized with digitonin. The membrane
fractions were isolated, divided into aliquots,
and either left untreated or treated with
proteinase K or proteinase K supplemented
with Triton X-100 detergent. Activation of
PAR1 wild type resulted in a signiﬁcant accumulation of receptor in proteinase K–protected samples compared with cells not
treated with agonist (Figure 6A, lanes 2 and
5). PAR1 accumulation was diminished in
cells treated with Triton X-100, which allows
proteinase K access to internal compartments (Figure 6A, lanes 5 and 6). These ﬁndings suggest that activated PAR1 wild type
trafﬁcs to a protected endosomal compartment and is consistent with its sorting to ILVs
of MVBs (Dores et al., 2012). In contrast to
wild-type receptor, activated PAR1 ASIA
mutant failed to accumulate in compartments resistant to proteinase K digestion
(Figure 6A, lanes 8 and 11), suggesting that
mutant receptor fails to trafﬁc to protected
endosomal compartments. Degradation of
the peripheral endosomal–associated protein EEA1 was examined in parallel and was
detected only in samples not incubated with
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FIGURE 5: A PAR1 mutant defective in AP-3 binding fails to sort to MVBs/lysosomes. (A) HeLa cells expressing PAR1
wild type (WT) or ASIA mutant were preincubated with anti-FLAG antibody at 4°C to ensure that only surface receptors
were labeled. Cells were pretreated with 0.2 mM leupeptin and then either left unstimulated (0 min) or stimulated with
100 μM SFLLRN for the indicated times, ﬁxed, permeabilized, and immunostained with anti-EEA1 antibody and
processed for confocal microscopy. Insets, magniﬁcations of boxed areas. Colocalization of PAR1 (red) and EEA1 (green)
is indicated by the yellow color in the merged images and was quantitated by determining Pearson’s r from six different
cells from multiple independent experiments. The difference in PAR1 and EEA1 colocalization detected at 10 min was
signiﬁcant compared with 0 min control cells (***p < 0.001; n  6) as determined by Student’s t test. Scale bar, 10 μm.
(B) PAR1 WT or ASIA mutant expressing HeLa cells pretreated with 0.2 mM leupeptin were labeled with anti-FLAG
antibody, stimulated with 100 μM SFLLRN for 30 min, immunostained with anti–LAMP-1 and processed for confocal
microscopy as described. Insets, magniﬁcations of boxed areas. Colocalization of PAR1 (red) and LAMP-1 (green) is
indicated by the yellow color in the merged images and quantitated by determining Pearson’s r from six different cells
taken from three separate experiments. The difference between PAR1 WT and ASIA with LAMP-1 at 30 min was
signiﬁcant (**p < 0.01; n  6) as determined by Student’s t test. Scale bar, 10 μm.

proteinase K (Figure 6A), indicating that plasma membrane permeabilization and proteinase K activity remained intact under these
conditions.
We next examined PAR1 wild-type and ASIA mutant accumulation in intralumenal membranes of enlarged endosomes induced
by Rab5 Q79L mutant coexpression to assess MVB sorting. In untreated control cells, PAR1 wild type and ASIA mutant localized to
the cell surface, whereas Rab5 Q79L mutant fused to green ﬂuorescent protein (GFP) was present predominantly at the limiting membrane of enlarged endosomes (Figure 6B). After 20 min of agonist
stimulation, PAR1 wild type showed substantial accumulation within
the lumen of Rab5 Q79L–positive endosomes (Figure 6B). In contrast, PAR1 ASIA mutant remained at the limiting membrane of enlarged endosomes induced by Rab5 Q79L mutant expression (Figure 6B). A line scan analysis through the center of representative
endosomes also indicates that PAR1 wild type localizes to the lumen of Rab5 Q79L–positive endosomes, whereas PAR1 ASIA is restricted to the limiting membrane (Figure 6B). Taken together, these
ﬁndings suggest that both the PAR1 C-tail–proximal, tyrosine-based
motif and AP-3 are important for receptor sorting to MVBs/
lysosomes.
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AP-3 facilitates PAR1 interaction with ALIX
In recent work, we showed that PAR1 sorts to ILVs of MVBs via direct
interaction with ALIX, an adaptor protein that links PAR1 to the
ESCRT-III machinery and ILV/MVB sorting, independent of ubiquitination (Dores et al., 2012). To determine the mechanism by which
AP-3 regulates PAR1 sorting to lysosomes, we ﬁrst examined whether
AP-3 was necessary for agonist-promoted PAR1 association with
ALIX. HeLa cells stably expressing PAR1 were transfected with nonspeciﬁc or D-adaptin–speciﬁc siRNAs and then incubated with agonist for various times. PAR1 was immunoprecipitated, and the
association of endogenous ALIX was assessed. In control siRNA–
transfected cells, agonist-induced a marked increase in PAR1 recruitment of endogenous ALIX at 10 min (Figure 7A, lanes 1 and 2). These
ﬁndings are consistent with the kinetics of ALIX recruitment to activated PAR1 in HeLa cells as previously reported (Dores et al., 2012).
Remarkably, however, in cells deﬁcient in AP-3 expression, agonist
activation of PAR1 failed to promote recruitment of endogenous
ALIX (Figure 7A, lanes 3 and 4). These results suggest that AP-3 is
important for mediating the interaction between PAR1 and ALIX.
To conﬁrm these ﬁndings, we examined whether a PAR1 mutant
defective in AP-3 binding retained the capacity to bind to ALIX
Molecular Biology of the Cell

(Dores et al., 2012). HeLa cells expressing
PAR1 wild type and Y206A mutant were
stimulated with agonist and immunoprecipitated with anti-PAR1 antibody, and AP-3 association was examined. Similar to wild-type
PAR1, agonist induced a marked increase in
AP-3 interaction with PAR1 Y206A mutant
after 10 min of agonist stimulation (Figure
7C, lanes 2 and 4). These data indicate that
activated PAR1 associates with AP-3 before
interaction with ALIX and sorting to ILVs of
MVBs.

PAR1 and AP-3 localization is not
disrupted by Vps4 E228Q mutant
To determine whether AP-3 localization is
dependent on ESCRT function, we examined PAR1 and AP-3 subcellular distribution
in cells expressing the Vps4 E228Q mutant.
Vps4 is an AAA-ATPase that catalyzes ESCRT-III disassembly and recycling and is essential for ESCRT function (Hurley and Hanson, 2010). HeLa cells expressing PAR1 or
PAR2 and either Vps4 wild type or E228Q
mutant fused to GFP were incubated with
anti-FLAG antibody at 4°C to label the cell
surface cohort, stimulated with agonist, and
immunostained with SA4 anti–D-adaptin antibodies. Expression of Vps4 wild type resulted in diffuse distribution throughout the
cytoplasm, whereas Vps4 E228Q mutant accumulated in vacuolar-like structures (Figure
FIGURE 6: PAR1 mutant defective in AP-3 binding fails to sort to intralumenal membranes.
8). In the absence of agonist, PAR1 localized
(A) HeLa cells expressing FLAG-PAR1 wild type (WT) or ASIA mutant were either left untreated
to the plasma membrane in Vps4 wild type–
(Ctrl) or treated with 100 μM SFLLRN (+SF) for 15 min at 37°C. Membranes were isolated,
and E228Q mutant–expressing cells
divided into three fractions, and were left untreated or treated with proteinase K or proteinase
(Figure 8A). After activation, PAR1 relocalK supplemented with 0.1% Triton X-100 detergent. The samples were then immunoblotted for
ized to endocytic vesicles of normal morthe presence of PAR1 or the peripheral endosomal protein EEA1, a control for plasma
phology in Vps4 wild type–expressing cells
membrane permeabilization and proteinase K activity. The data (mean o SD) are expressed as
and showed minimal accumulation in Vps4
the fraction of PAR1 remaining after proteinase K treatment as compared with the untreated
control (–) from either the Ctrl or +SF-treated samples from three independent experiments and E228Q mutant–positive vacuoles (Figure
were analyzed by Student’s t test (**p < 0.01; n  3). (B) HeLa cells expressing PAR1 WT or ASIA 8A), consistent with previously reported remutant transiently transfected with Rab5 Q79L mutant were pretreated with 0.2 mM leupeptin,
sults (Dores et al., 2012). In contrast, actistimulated with agonist, and processed as described. Insets, magniﬁcations of boxed areas.
vated PAR2 internalized and accumulated
Arrowheads indicate PAR1 WT within enlarged endosomes, and triangles indicate PAR1 ASIA at
predominantly in Vps4 E228Q–positive vacthe limiting membrane of enlarged endosomes. The line scan analysis demonstrates
uoles (Figure 8B), consistent with disruption
ﬂuorescence intensity within the lumen of the representative endosomes. Normalized
of ubiquitin-dependent MVB sorting of
ﬂuorescence intensity represents the pixel intensity measured across the dashed gray line,
PAR2 (Dores et al., 2012). Of interest, in
where maximum intensity is set to 100. Normalized distance represents the diameter measured
across the dashed gray line, where maxima representing the limiting membrane are labeled as 0 both Vps4 wild type– and E228Q mutant–
expressing cells, AP-3–positive puncta
and 100 (white dashed lines).
maintained a similar morphology and distribution (Figure 8). Thus the canonical ESCRT machinery does not
or whether a mutant PAR1 with impaired ALIX binding interacted
appear to critically regulate PAR1 or AP-3 subcellular localization as
with AP-3. HeLa cells stably expressing PAR1 wild type or ASIA mucompared with PAR2, a cargo that requires ubiquitin for lysosomal
tant were stimulated with agonist for 10 min; PAR1 was immunopredegradation. Taken together, these ﬁndings suggest a function for
cipitated, and association with ALIX was assessed. Compared to
AP-3 in regulation of PAR1 lysosomal sorting that appears distinct
wild-type PAR1, the PAR1 ASIA mutant with impaired AP-3 binding
from the canonical ubiquitin- and ESCRT-dependent sorting pathshowed minimal coassociation with endogenous ALIX after agonist
way (Figure 9).
stimulation (Figure 7B, lanes 2 and 4). These results indicate that
disruption of PAR1 interaction with AP-3 prevents binding to ALIX,
an adaptor protein important for sorting PAR1 to ILVs of MVBs. To
DISCUSSION
determine whether PAR1 binding to AP-3 is dependent on receptor
In the present study, we describe a new function for AP-3 in the
interaction with ALIX, we examined whether AP-3 associated with
sorting of a signaling receptor from early endosomes to MVBs/
the PAR1 Y206A mutant, a receptor variant that cannot bind ALIX
lysosomes that occurs independent of ubiquitin and the canonical
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FIGURE 7: AP-3 mediates PAR1 interaction with ALIX. (A) HeLa cells
expressing FLAG-PAR1 wild type (WT) were transfected with 50 nM
nonspeciﬁc (ns) or D-adaptin siRNAs. Cells were left unstimulated
(0 min) or stimulated with 100 μM SFLLRN for 10 min, and equivalent
amounts of cell lysates were immunoprecipitated with anti-PAR1
antibody. Immunoprecipitates were analyzed for the presence of
endogenous ALIX and PAR1. The expression of D-adaptin, ALIX, and
actin in total cell lysates was examined by immunoblotting as controls.
(B) HeLa cells expressing FLAG-PAR1 WT or ASIA mutant were left
untreated (0 min) or treated with 100 μM SFLLRN for 10 min.
Equivalent amounts of cell lysates were immunoprecipitated with
anti-PAR1 antibody, and the coassociation of endogenous ALIX was
assessed by immunoblot. Cell lysates were immunoblotted for ALIX
expression as a control. (C) HeLa cells expressing FLAG-PAR1 WT or
Y206A mutant were either unstimulated (0 min) or stimulated with
100 μM SFLLRN for 10 min. PAR1 was immunoprecipitated, and the
coassociation of endogenous AP-3 was determined by
immunoblotting using D-adaptin antibody. The expression of D-adaptin
in total cell lysates was examined in parallel as a control.

ESCRT machinery. We found that PAR1 and AP-3 coassociate on
endocytic vesicles after agonist stimulation. Our studies also show
that AP-3 regulates PAR1 lysosomal degradation independent of
3620 | M. R. Dores et al.

ubiquitination. In addition, we identiﬁed a PAR1 C-tail–localized,
tyrosine-based motif that mediates AP-3 interaction and receptor
sorting to intralumenal membranes of the sorting endosome—a
compartment protected from proteinase K digestion. Remarkably,
AP-3 is also required for PAR1 interaction with ALIX, which recruits
ESCRT-III to facilitate receptor sorting to ILVs of MVBs (Dores et al.,
2012), suggesting that AP-3 functions before PAR1 engagement of
ALIX. Moreover, disruption of the canonical ubiquitin- and ESCRTdependent sorting pathway by coexpression of the Vps4 E228Q
mutant failed to perturb AP-3– or PAR1–containing sorting endosomes. Thus AP-3 mediates endocytic sorting of PAR1 through an
ALIX-dependent and ubiquitin-independent pathway, indicating
that AP-3 regulates a distinct GPCR MVB/lysosomal sorting pathway
in mammalian cells (Figure 9).
A critical step in MVB/lysosome sorting is the retention of cargo
in early endosomes and subsequent incorporation into ILVs. We
previously showed that activated PAR1 sorts to ILVs of MVBs independent of ubiquitination and ubiquitin-binding ESCRT components (Gullapalli et al., 2006; Wolfe et al., 2007; Dores et al., 2012).
In recent work, we demonstrated that ALIX binds directly to PAR1
and recruits ESCRT-III to mediate receptor sorting to ILVs of MVBs
(Dores et al., 2012). However, the mechanisms responsible for initiating PAR1 sorting at the early sorting endosome remained unclear.
In these studies, we show that PAR1 sorting to MVBs/lysosomes and
interaction with ALIX is impaired in cells depleted of endogenous
AP-3. Similar results were observed with a PAR1 tyrosine motif mutant defective in AP-3 binding. Thus we propose that AP-3 regulates
PAR1 sorting at the early endosome before ALIX engagement and
ILV sorting at the MVB. This pathway is distinct from the canonical
ESCRT-dependent ILV/MVB sorting pathway of ubiquitinated receptors. In the canonical pathway, ubiquitinated receptors are sequestered at the early endosome in an HRS-enriched subdomain coated
with clathrin and then sorted into ILVs of MVBs (Raiborg et al., 2002).
A similar HRS-dependent mechanism has been implicated in lysosomal sorting of both ubiquitinated and nonubiquitinated GPCRs
(Marchese et al., 2003; Hislop et al., 2004; Hasdemir et al., 2007;
Henry et al., 2011). However, HRS is not required for PAR1 lysosomal degradation (Gullapalli et al., 2006). Rather than HRS, our
ﬁndings suggest that AP-3 interacts with PAR1 on endosomes and
links the receptor to ALIX to facilitate ILV sorting to MVBs independent of ubiquitination.
AP-3 regulates lysosomal sorting of LAMPs and CD63 by binding directly to C-tail–localized tyrosine motifs (Bonifacino and
Traub, 2003). Previous studies reported that ﬁbroblasts derived
from mice or Hermansky–Pudlak syndrome patients, which harbor
mutations in the B3- or D-adaptin subunits of AP-3, exhibited reduced AP-3 expression and missorting of LAMP-1, LAMP-2, and
CD63 to the cell surface (Dell’Angelica et al., 1999; Peden et al.,
2004). In addition, LAMPs and CD63 contain canonical tyrosinebased motifs within their C-tails that mediate interaction with the
μ3-adaptin subunit of AP-3 and lysosomal sorting (Williams and
Fukuda, 1990; Gough and Fambrough, 1997; Rous et al., 2002).
PAR1 contains two C-tail tyrosine-sorting motifs: a proximal motif
located 11 residues from the transmembrane domain and a distal
motif present at the extreme C-terminus (Figure 4A). In many
cases, lysosomal-targeting tyrosine sorting signals are located
within 6–13 residues from the transmembrane domain (Bonifacino
and Traub, 2003). Consistent with this paradigm, our studies indicate that the PAR1 proximal C-tail tyrosine motif is critical for
AP-3–mediated lysosomal sorting, since mutations in the proximal
but not the distal motif resulted in impaired lysosomal degradation
and AP-3 binding. Thus the PAR1 proximal tyrosine-based motif
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teins independent of the canonical ESCRT
machinery via two different ILV sorting pathways mediated by the sphingolipid ceramide and ALIX/ESCRT-III. Of interest, ALIX
also binds to lysobisphosphatidic acid
(LBPA), a phospholipid enriched in late endosomes (Matsuo et al., 2004). However,
the function of LBPA in PAR1 sorting to ILVs
of MVBs remains to be determined.
In addition to PAR1, AP-3 has been
shown to regulate trafﬁcking of other mammalian GPCRs. In mouse neuroblastoma
cells, the cannabinoid receptor-1 (CB1R) localizes predominantly to intracellular compartments and exhibits partial colocalization with AP-3 (Rozenfeld and Devi, 2008).
Moreover, depletion of AP-3 resulted in increased expression of CB1R at the cell surface, suggesting that AP-3 regulates either
CB1R endosome to lysosome sorting or retention in endosomes. The mechanism by
which AP-3 facilitates trafﬁcking of CB1R is
not known, since neither tyrosine nor dileucine sorting motifs are present in the receptor cytoplasmic domains. In addition to
CB1R, a function for the neuronal speciﬁc
AP-3 isoform in recycling of the muscarinic
acetylcholine M5 receptor in neurons has
been demonstrated (Bendor et al., 2010).
However, AP-3 was shown to associate with
FIGURE 8: PAR1 and AP-3 subcellular localization in Vps4-expressing cells. HeLa cells stably
M5 muscarinic receptor indirectly via AGAP1,
expressing FLAG-PAR1 (A) or FLAG-PAR2 (B) were transiently transfected with Vps4-GFP or
an ArfGAP protein that binds directly to the
Vps4 E228Q-GFP. Cells were incubated with 0.2 mM leupeptin and then incubated with
M5 receptor and AP-3. These ﬁndings suganti-FLAG antibody at 4ºC to label the surface cohort, washed, and either left untreated (0 min)
gest that AP-3 exhibits multiple functions in
or treated with PAR-speciﬁc agonist peptides for the indicated times. Cells were ﬁxed,
immunostained for PAR1 and endogenous AP-3, and visualized by confocal microscopy. Cells
the regulation of GPCR trafﬁcking in distinct
expressing Vps4 are indicated by arrowheads. The colocalization of PAR (red) with Vps4 (green)
cell types, including endosome-to-lysosome
is indicated by the yellow color shown in the merged image. Endogenous AP-3 was detected in
sorting, as well as in receptor recycling.
the same cells and is shown in the adjacent panels. Insets, magniﬁcations of boxed areas. Scale
In summary, our work provides insight
bar, 10 μm.
into a new mechanism by which MVB sorting of a signaling receptor is initiated at enfunctions as a dominant signal for AP-3 association and lysosomal
dosomes independent of ubiquitin and HRS, a ubiquitin-binding
sorting.
ESCRT component. We show that the classic adaptor protein AP-3
Previous studies indicated that AP-3 localizes at budding sites of
regulates PAR1 sorting to ILVs of MVBs by facilitating interaction
tubule-sorting endosomes containing LAMP-1 and LAMP-2 and dewith ALIX, an ESCRT-III–interacting protein. These studies deﬁne a
ﬁned a new pathway for lysosomal transport of proteins (Peden
new pathway that can be used by signaling receptors to access ILVs
et al., 2004). In addition to LAMP-1 and LAMP-2, which reside at the
of MVBs that is independent of ubiquitination and ubiquitin-binding
limiting membrane of MVBs/lysosomes, AP-3 function is also essencomponents of the ESCRT machinery. In addition, we previously
tial for sorting of CD63, a protein that is enriched in ILVs of MVBs
showed that activated PAR1 sorts to lysosomes through a pathway
(Dell’Angelica et al., 1999; Peden et al., 2004; Pols and Klumperthat is regulated by sorting nexin-1 (Gullapalli et al., 2006); however,
man, 2009). Of interest, the incorporation of CD63 into ILVs of MVBs
the connection between sorting nexins and AP-3 function in PAR1
is mediated by the sphingolipid ceramide and occurs independent
trafﬁcking is not known and will be important to determine.
of the ESCRT machinery. CD63 is segregated into endosomal membrane subdomains containing ceramide, which appears to aggreMATERIALS AND METHODS
gate resulting in inward budding of ILVs (Trajkovic et al., 2008).
Reagents and antibodies
These ﬁndings suggest that distinct trafﬁcking events regulated by
The peptide agonists SFLLRN (PAR1 speciﬁc) and SLIGKV (PAR2
AP-3 and subsequent sequestration into a lipid microdomain medispeciﬁc) were synthesized as the carboxyl amide and puriﬁed by
ate CD63 sorting into ILVs of MVBs. Different trafﬁcking processes
high-pressure liquid chromatography at the Tufts University Core
also regulate the trafﬁcking of PAR1 into ILVs of MVBs. Similar to
Facility (Boston, MA). SDF-1A was purchased from Sigma-Aldrich
CD63, AP-3 mediates the targeting of PAR1 to MVBs/lysosomes.
(St. Louis, MO). Rabbit anti-PAR1 antibody was generated against
However, in contrast to CD63, AP-3 facilitates PAR1 interaction with
the N-terminal domain of PAR1 encompassing the hirudin-like reALIX, which recruits ESCRT-III to mediate receptor sorting to ILVs
gion as described (Paing et al., 2006). M1 and M2 anti-FLAG
of MVBs (Dores et al., 2012). Thus AP-3 functions to sort cargo proand anti–B-actin antibodies were from Sigma-Aldrich. Monoclonal
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GPCR degradation assays

FIGURE 9: Model of AP-3 regulation of PAR1 MVB/lysosomal sorting. After internalization,
PAR1 trafﬁcs to an endosomal sorting compartment and associates with AP-3, an adaptor
protein that is known to colocalize with clathrin on endosomes, but whether clathrin is recruited
to PAR1 is not known. AP-3 binds to PAR1 via a proximal C-tail, tyrosine-based sorting motif
independent of receptor ubiquitination. The interaction between PAR1 and AP-3 retains it at the
sorting endosome and facilitates its interaction with ALIX. Thus AP-3 binds to PAR1 before
engagement of ALIX. PAR1 interaction with ALIX occurs at the late endosome/ MVB. ALIX also
recruits ESCRT-III components—charged multivesicular body protein 4 (CHMP4) and CHMP2—
to facilitate PAR1 sorting to ILVs of MVBs. The AAA-ATPase Vps4 mediates ESCRT-III
disassembly and recycling and is critical for ESCRT function.

anti-EEA1 and anti–D-adaptin antibodies were obtained from BD
Biosciences (San Jose, CA). Rat monoclonal anti-CXCR4 (2B11) was
previously described (Marchese and Benovic, 2001). The monoclonal anti–D-adaptin (SA4) and LAMP-1 antibodies were obtained from
the Developmental Studies Hybridoma Bank (University of Iowa,
Iowa City, IA). Anti–B-tubulin was purchased from Accurate Chemical (Westbury, NY). Anti-ALIX monoclonal antibody was purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase–conjugated goat anti-mouse and anti-rabbit were from BioRad (Hercules, CA). Alexa Fluor 488–, 594–, and 647–conjugated
goat anti-mouse and anti-rabbit antibodies were obtained from Invitrogen (Carlsbad, CA).

cDNAs and cell lines
A cDNA plasmid encoding PAR1 wild type containing an N-terminal
FLAG epitope and various mutants was previously described (Paing
et al., 2006; Dores et al., 2012). The N-terminal FLAG-tagged PAR2
cDNA plasmid was previously described (Stalheim et al., 2005).
HeLa cells stably expressing FLAG-tagged PAR1 wild type and mutants, as well as FLAG-tagged PAR2 wild type, were generated and
maintained as previously described (Paing et al., 2006; Ricks and
Trejo, 2009). GFP-tagged Vps4 and Rab5 were previously described
(Marchese et al., 2003; Gullapalli et al., 2004).

Cell transfections
Transient transfections with cDNA plasmids cells were performed
using Lipofectamine reagent (Invitrogen) according to manufacturer’s directions. HeLa cells were transiently transfected with 50 nM
nonspeciﬁc (ns) siRNA (5`-CTACGTCCAGGAGCGCACC-3`) or Dsubunit SMARTpool siRNAs purchased from Dharmacon (Lafayette,
CO) using Lipofectamine 2000 (Invitrogen) for 60 h at 37°C as previously described (Paing et al., 2006; Dores et al., 2012).

PAR1 internalization assays
PAR1 internalization was examined by cell surface ELISA as previously described (Paing et al., 2004).
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CXCR4 degradation was assessed as described previously (Marchese and Benovic,
2001). Brieﬂy, HeLa cells were washed with
cold phosphate-buffered saline (PBS), solubilized in 300 μl of 2r sample buffer containing 0.0375 M Tris-HCl, pH 6.5, 8% SDS,
10% glycerol, 5% B-mercaptoethanol, and
0.003% bromophenol blue, and sonicated,
and equal amounts of lysates were resolved
by SDS–PAGE, transferred, and immunoblotted to detect endogenous CXCR4. Immunoblots were stripped and reprobed with
anti-tubulin. PAR1 and PAR2 degradation
was assessed from an equivalent amount of
cell lysates that were directly analyzed by
SDS–PAGE, followed by immunoblotting or
by immunoprecipitation, SDS–PAGE, and
immunoblotting as previously described
(Dores et al., 2012).

Immunoﬂuorescence confocal
microscopy

HeLa cells stably expressing PAR1 or PAR2
were processed, ﬁxed, permeabilized, immunostained with species-speciﬁc secondary antibodies conjugated to
Alexa Fluor 488, 594, or 647, and imaged by confocal microscopy as
previously described (Paing et al., 2006; Dores et al., 2012). AP-3 immunostaining was performed essentially as described (Berger et al.,
2007). Images shown in Figures 1, 2, and 8 were collected using a
FluoView 300 laser scanning confocal imaging system (Olympus,
Tokyo, Japan) conﬁgured with an IX70 microscope ﬁtted with a
PlanApo 60r oil objective. Confocal images (XY-sections at 0.28 μm)
were collected sequentially at 800 r 600 resolution with 2r optical
zoom using FluoView software. All other images were collected using
an Olympus IX81 DSU spinning disk confocal microscope conﬁgured
with a PlanApo 60r oil objective and Hamamatsu ORCA-ER digital
camera (Hamamatsu, Hamamatsu, Japan). Fluorescent images of
XY-sections at 0.28 μm were collected sequentially using SlideBook
4.2 software (Intelligent Imaging Innovations, Denver, CO). Pearson’s r
for quantifying PAR1 colocalization with EEA1, LAMP-1, and AP-3 was
calculated for six cells from multiple independent experiments using
either SlideBook 4.2 software or ImageJ 1.45 (National Institutes of
Health, Bethesda, MD). Line scan analysis was performed using SlideBook 4.2 software, and ﬂuorescence intensity and distance were normalized as previously reported (Henry et al., 2011). The ﬁnal composite images were created using Photoshop CS (Adobe, San Jose, CA).

Proteinase K protection assays
The proteinase K protection assay was performed as described with
minor modiﬁcations (Malerod et al., 2007). HeLa cells were plated in
six-well culture dishes (4.0 r 105 cells/well), grown overnight at 37°C,
and treated with or without agonist. Cells were placed on ice and
incubated for 5 min with PBS, harvested, and gently permeabilized
using 6.5 μg/ml digitonin. Membranes were collected by centrifugation and resuspended in buffer containing 100 mM K2HPO4/KH2PO4,
5 mM MgCl2, and 250 mM sucrose. Membranes were then divided
into three aliquots left untreated, treated with 2.5 ng/ml proteinase
K, or treated with proteinase K supplemented with 0.1% Triton-X
100 for 10 min at room temperature. After treatments, samples were
diluted with 100 μl of 2r SDS sample buffer containing 20 mM phenylmethylsulfonyl ﬂuoride and analyzed by immunoblot.
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Data analysis
Data were analyzed using Prism 4.0 software (GraphPad Software,
La Jolla, CA), and statistical signiﬁcance was determined using Student’s t test and two-way analysis of variance (ANOVA) with InStat
3.0 (GraphPad)
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